Acute Myeloid Leukemia with FLT3 Mutation

Acute Myeloid Leukemia with FLT3 Mutation — Trials · CancerIndex

Clinical trials

Registered studies

15 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4
Recruiting: 3
Ph III recruiting: 0
Growth YoY: —
Industry share: 50%
Top sponsor: Shijiazhuang Yiling Pharmaceutical Co. Ltd
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (4)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05596968	The Gut Microbiome and Sorafenib Maintenance Therapy in FLT3-ITD Positive AML After Allo-HSCT	unknown	—	37	Nanfang Hospital, Southern Medical UniversityOTHER	1	Oct 27, 2022	clinicaltrials
NCT05596981	The Gut Microbiome in FLT3-ITD+ AML Undergoing Allo-HSCT With Or Without Sorafenib Maintenance After Allo-HSCT	unknown	—	60	Nanfang Hospital, Southern Medical UniversityOTHER	1	Oct 27, 2022